» Articles » PMID: 32771976

Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges

Overview
Journal iScience
Publisher Cell Press
Date 2020 Aug 11
PMID 32771976
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Rapid spread of coronavirus disease 2019 (COVID-19) is ravaging the globe. Since its first report in December 2019, COVID-19 cases have exploded to over 14 million as of July 2020, claiming more than 600,000 lives. Implementing fast and widespread diagnostic tests is paramount to contain COVID-19, given the current lack of an effective therapeutic or vaccine. This review focuses on a broad description of currently available diagnostic tests to detect either the virus (SARS-CoV-2) or virus-induced immune responses. We specifically explain the working mechanisms of these tests and compare their analytical performance. These analyses will assist in selecting most effective tests for a given application, for example, epidemiology or global pandemic research, population screening, hospital-based testing, home-based and point-of-care testing, and therapeutic trials. Finally, we lay out the shortcomings of certain tests and future needs.

Citing Articles

Performance of rapid antigen tests to detect SARS-CoV-2 variant diversity and correlation with viral culture positivity: implication for diagnostic development and future public health strategies.

Goux H, Green J, Wilson A, Sozhamannan S, Richard S, Colombo R mBio. 2024; 15(12):e0273724.

PMID: 39480114 PMC: 11633148. DOI: 10.1128/mbio.02737-24.


Sensitive methods for detection of SARS-CoV-2 RNA.

Chen X, Xia S Methods Microbiol. 2024; 50:1-26.

PMID: 38620918 PMC: 8283572. DOI: 10.1016/bs.mim.2021.06.001.


Paper-based devices for rapid diagnostics and testing sewage for early warning of COVID-19 outbreak.

Hui Q, Pan Y, Yang Z Case Stud Chem Environ Eng. 2024; 2:100064.

PMID: 38620545 PMC: 7700740. DOI: 10.1016/j.cscee.2020.100064.


Reply to the letter to the editor "before attributing impaired cognition in the elderly to COVID-19, all influencing factors must be considered".

Rizzi G, Albanese E Brain Behav Immun Health. 2024; 37:100740.

PMID: 38618011 PMC: 11010793. DOI: 10.1016/j.bbih.2024.100740.


Advances and Challenges in SARS-CoV-2 Detection: A Review of Molecular and Serological Technologies.

El-Daly M Diagnostics (Basel). 2024; 14(5).

PMID: 38472991 PMC: 10931201. DOI: 10.3390/diagnostics14050519.


References
1.
Callahan C, Lee R, Zulauf K, Tamburello L, Smith K, Previtera J . Open Development and Clinical Validation of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck. J Clin Microbiol. 2020; 58(8). PMC: 7383530. DOI: 10.1128/JCM.00876-20. View

2.
Xie C, Jiang L, Huang G, Pu H, Gong B, Lin H . Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis. 2020; 93:264-267. PMC: 7129110. DOI: 10.1016/j.ijid.2020.02.050. View

3.
Yu L, Wu S, Hao X, Dong X, Mao L, Pelechano V . Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform. Clin Chem. 2020; 66(7):975-977. PMC: 7188121. DOI: 10.1093/clinchem/hvaa102. View

4.
Daley P, Castriciano S, Chernesky M, Smieja M . Comparison of flocked and rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and symptomatic patients. J Clin Microbiol. 2006; 44(6):2265-7. PMC: 1489401. DOI: 10.1128/JCM.02055-05. View

5.
Lu R, Wu X, Wan Z, Li Y, Zuo L, Qin J . Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2. Virol Sin. 2020; 35(3):344-347. PMC: 7110266. DOI: 10.1007/s12250-020-00218-1. View